Rockwell Medical (RMTI) Receivables (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Receivables came in at $8.8 million in Q1 2026, down 8.74% YoY from $9.7 million in Q1 2025, and up 8.38% on a QoQ basis from $8.1 million in Q4 2025.
Rockwell Medical (RMTI) Receivables (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Receivables data on file, last reported at $8.8 million in Q1 2026.
- Quarterly Receivables fell 8.74% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 8.74% YoY) and the FY2025 annual result came in at $8.1 million, down 1.79% from the prior year.
- Receivables climbed to $8.8 million in Q1 2026, from $8.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $16.2 million in Q2 2022 to a low of $5.4 million in Q2 2023.
- A 5-year average of $10.1 million and a median of $9.4 million in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables tumbled 66.56% — and 2024, when it surged 100.33%.
- Tracing RMTI's Receivables over 5 years: stood at $12.5 million in 2022, then fell by 12.92% to $10.9 million in 2023, then declined by 23.94% to $8.3 million in 2024, then decreased by 1.79% to $8.1 million in 2025, then rose by 8.38% to $8.8 million in 2026.
- The last three Receivables figures came in at $8.8 million (Q1 2026), $8.1 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 8.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.31 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2025 | 8.14 Mn |
| Sep 30, 2025 | 8.33 Mn |
| Jun 30, 2025 | 8.08 Mn |
| Mar 31, 2025 | 9.67 Mn |
| Dec 31, 2024 | 8.29 Mn |
| Sep 30, 2024 | 8.89 Mn |
| Jun 30, 2024 | 10.84 Mn |
| Mar 31, 2024 | 11.09 Mn |
| Dec 31, 2023 | 10.90 Mn |
| Sep 30, 2023 | 9.36 Mn |
| Jun 30, 2023 | 5.41 Mn |
| Mar 31, 2023 | 6.02 Mn |
| Dec 31, 2022 | 12.52 Mn |
| Sep 30, 2022 | 14.73 Mn |
| Jun 30, 2022 | 16.18 Mn |
| Mar 31, 2022 | 14.24 Mn |
| Dec 31, 2021 | 11.83 Mn |
| Sep 30, 2021 | 12.07 Mn |